← Back to Search

Active Life for Chronic Obstructive Pulmonary Disease (ActiveCOPD Trial)

N/A
Waitlist Available
Led By Janet L Larson, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline, end of 10 week intervention and at 3, 6, and 12 months after the completion of the 10 week intervention
Awards & highlights

ActiveCOPD Trial Summary

This trial looks at whether a lifestyle and exercise program can help people with chronic obstructive pulmonary disease be more active. If successful, the program could be used to improve the health of people with COPD.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease (COPD)

ActiveCOPD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline, end of 10 week intervention and at 3, 6, and 12 months after the completion of the 10 week intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline, end of 10 week intervention and at 3, 6, and 12 months after the completion of the 10 week intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time Spent in Physical Activity as Measured by Upright Time (Minutes Per Day) Monitored by ActivPal Monitor
Time Spent in Sedentary Behavior
Secondary outcome measures
Six-minute Walk Test
Other outcome measures
Barriers Efficacy for Physical Activity Scale: Chronic Obstructive Pulmonary Disease
Chronic Respiratory Questionnaire Dyspnea Scale
Multidimensional Outcomes Expectations Scale
+5 more

ActiveCOPD Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active LifeExperimental Treatment1 Intervention
The Active Life intervention includes structured walking, functional circuit training, stretching and behavior/educational components.
Group II: Chair exercisesPlacebo Group1 Intervention
The Chair exercise intervention includes chair exercises, behavioral relaxation and health education.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Active Life
2017
N/A
~190

Find a Location

Who is running the clinical trial?

National Institute of Nursing Research (NINR)NIH
584 Previous Clinical Trials
10,379,105 Total Patients Enrolled
University of MichiganLead Sponsor
1,809 Previous Clinical Trials
6,384,911 Total Patients Enrolled
Janet L Larson, PhDPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
23 Total Patients Enrolled
~23 spots leftby Jun 2025